Tests diet and exercise to prevent knee osteoarthritis in women with obesity
Tests diet, exercise and weight-loss maintenance to prevent knee arthritis in women.
Key facts
- Who runs it
- Wake Forest University
- Where
- Boston, Chapel Hill, and Winston-Salem, United StatesSee the 3 sitesAlso in 1 other country, 1 site
- Trial code
- Registry title
- The Osteoarthritis Prevention Study
- Status
- Recruiting
- People taking part
- 1,230 people, planned
- Started
- 21 Mar 2024
- Expected to end
- 31 Jul 2029
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Diet and Exercise
- Record updated
- 23 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 50 or older with obesity who have no knee osteoarthritis and no or only occasional knee pain. It tests diet, exercise and weight-loss maintenance to prevent knee osteoarthritis.
- Age
- 50 years or older
- Sex
- Women only
- Disease stage
- No osteoarthritis in the knee on x-ray and MRI; no or infrequent knee pain (fewer than 15 days a month) in the same knee
- Earlier treatment
- No knee injection in the past 6 months; no knee fracture or ligament or meniscus injury in the past 12 months
- Biomarker or test result
- BMI of 30 kg/m2 or higher
Main reasons for not taking part
- Severe or symptomatic coronary artery disease
- Cannot walk without a device
- Type 1 diabetes or active treatment for cancer
- Knee osteoarthritis in both knees (by x-ray, MRI or frequent pain)
- Cannot have an MRI (for example claustrophobia or body weight over 300 lbs (136 kg))
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Female
- BMI ≥ 30 kg/m2
- An eligible knee will have no OA by xray and MRI
- No or infrequent knee pain (< 15 days/month) in the same knee
Who cannot take part
- during the past 12 months knee fracture, anterior cruciate ligament (ACL), medial collateral ligament (MCL), or meniscus injury with or without surgical repair
- symptomatic or severe coronary artery disease
- type 1 diabetes
- active treatment for cancer
- unable to walk without a device
- blindness
- knee injection during the past 6 months
- bilateral knee OA by x-ray Kellgren-Lawrence (KL) ≥ 2
- bilateral knee OA by MRI
- bilateral symptomatic knee OA (frequent bilateral knee pain > 15 days per month)
- BMI< 30.0 kg/m2
- male sex
- claustrophobia
- contraindication to MRI including body weight > 300 lbs or knee coil does not fit
- unwillingness or inability to change eating and physical activity habits due to environment
- cannot speak and read English
- planning to leave area > 2 months during the 48-month intervention period
Where in United States
Also in 1 other country, 1 site
- Brigham and Women's HospitalBoston, United StatesContact: Paul OhTaking people
- University of North Carolina at Chapel HillChapel Hill, United StatesContact: Jovita NewmanNo longer taking part
- Wake Forest UniversityWinston-Salem, United StatesContact: Jovita NewmanTaking people
About the trial
What the trial wants to find out
The goal of this study is to establish the efficacy of an intervention of dietary weight loss, exercise, and weight-loss maintenance for knee Osteoarthritis (OA) prevention in adult females aged ≥ 50 years with obesity and no or infrequent knee pain. The primary aim is to compare the effects of a dietary weight loss, exercise, and weight-loss maintenance to an attention control group in preventing the development of structural Magnetic Resonance Imaging (MRI) knee OA. Secondary aims will determine the intervention effects on pain, mobility, health-related quality of life, knee joint compressive forces, inflammatory measures, weight loss, exercise self-efficacy, and cost-effectiveness of this intervention.
The 2 groups in the trial
- Attention ControlNo study treatment, for comparison
This comparison group provides attention, social interaction, and healthy lifestyle classes. There will be 4, 1-hour face-to-face group meetings per year featuring community health professionals, quarterly newsletters, and quarterly text messages.
- Diet and ExerciseTreatment being tested
The dietary component of the weight loss intervention is characterized by the frequency of contacts, methods to induce dietary restriction, and behavioral therapy strategies. The first 6 months of the diet program is an energy-restricted diet with the option of using partial meal replacements and nutritious snacks (Rapid Nutrition, PLC). The weight loss goal for the diet and exercise group is a minimum of 10% of baseline body weight by the end of year 1. The weight loss phase is followed by 3 years of a weight-loss maintenance program, with the goal of sustaining the achieved weight loss. The exercise component includes 60-minute sessions 2 days per week for 48 months.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Osteoarthritis Prevention Study
- Plain-language title
- Tests diet and exercise to prevent knee osteoarthritis in women with obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- The osteoarthritis prevention study (TOPS) - A randomized controlled trial of diet and exercise to prevent Knee Osteoarthritis: Design and rationale.Osteoarthritis and cartilage open, 2024
- Record updated
- 23 July 2026